3
Clinical Trials associated with AS-012A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AS012 IN SUBJECTS WITH NON-SEGMENTAL VITILIGO
A Phase II, Randomized, Double Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo
This is a randomized, double blind, placebo-controlled, phase II study. The study will be performed as a multicenter, multinational study.
A Phase 1, double-blind, randomized, placebo controlled study to assess the safety,tolerability and pharmacokinetics of single and multiple doses of AS012 administered orally inhealthy subjects.
Start Date27 Sep 2019 |
Sponsor / Collaborator- |
100 Clinical Results associated with AS-012
100 Translational Medicine associated with AS-012
100 Patents (Medical) associated with AS-012
100 Deals associated with AS-012